Home › Targets › FXN

FXN (4 companies · 6 programs)

Companies with an active program directed at FXN.

Lexeo Therapeutics, Inc. LXEO

  • LX2006 — Friedreich Ataxia Cardiomyopathy Phase 2
  • LX3010 — Friedreich Ataxia
  • LX3070 — Friedreich Ataxia Preclinical